Merck Sharp & Dohme fails to secure new nasal spray trial

12-02-2018

Merck Sharp & Dohme fails to secure new nasal spray trial

mihailgrey / iStockphoto.com

The US Court of Appeals for the Federal Circuit denied Merck Sharp & Dohme’s (MSD) request for a new trial to determine whether Amneal infringed a patent related to a nasal spray on Friday, February 9.


Merck Sharp & Dohme, Amneal, US Court of Appeals for the Federal Circuit, nasal spray, generics, ANDA, FDA

LSIPR